Related Experiment Videos
Summary
Anticoagulant proteins like antithrombin III can inhibit vasoconstriction, potentially protecting against cerebral vasospasm after subarachnoid hemorrhage (SAH). Other proteins show varied inhibitory effects on blood vessel responses.
Area of Science:
- Vascular biology
- Neuroscience
- Pharmacology
Background:
- Cerebral vasospasm is a dangerous complication of subarachnoid hemorrhage (SAH).
- Blood proteins may contribute to or prevent vasospasm by affecting blood vessel constriction.
Purpose of the Study:
- To quantify the inhibitory effects of antithrombin III on vasoconstriction in canine basilar arteries.
- To investigate whether other blood proteins also inhibit vasoconstriction induced by various agonists.
Main Methods:
- Isolated canine basilar arteries were exposed to cumulative doses of agonists (KCl, serotonin, UTP, thrombin).
- The inhibitory effects of antithrombin III, alpha2-macroglobulin, kallikrein, globulins, and fibrinogen were measured.
- Inhibition was assessed independently of endothelial function and sodium pump activity.
Main Results:
- Antithrombin III significantly inhibited responses to all tested agonists.
- Alpha2-macroglobulin inhibited responses to high K+, serotonin, and thrombin.
- Kallikrein inhibited responses to high K+ and serotonin via the endothelium and irreversibly blocked thrombin.
- Globulins and fibrinogen showed no inhibitory effects.
Conclusions:
- Anticoagulant proteins, particularly antithrombin III, are potent, non-specific inhibitors of vasoconstriction.
- Kallikrein selectively inhibits thrombin-induced constriction.
- Antithrombin III's potency suggests a protective role against cerebral vasospasm in SAH.